Citeline Podcasts

In this episode, HBW Insight catches up with IQVIA Consumer Health’s vice president of Global Consulting Services, Amit Shukla, to find out how the global consumer healthcare market is doing as it comes out of the pandemic. It’s good news, Shukla reveals, based on the firm’s latest intelligence. The market grew double digits in 2022 and is predicted to grow between 5 and 6% per year in the future - even faster if we see some of the innovative switches currently in the pipeline succeed. Looking ahead, Shukla points to artificial intelligence, sustainability and popular wellness ingredients as trends to watch that will drive future market growth.

Pink Sheet reporter and editors discuss the first round of mandated Medicare inflation rebates and new guidance on price negotiations, consider the VA’s decision to cover the Alzheimer’s drug Leqembi, and the US FDA continuing to search for a cell and gene therapy office leader.

Listen to expert opinions from PPD as they discuss recent survey results which gathered insights on the current and future investment landscape from emerging to mid-size pharmaceutical and biotech companies’ perspectives.

By Ashley Yeo:

Interviewing Gabriel Flemming of GTAI, Germany

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。

今回取り上げた記事はこちら 「Chinese Biotechs Ascend Deal-Making By Partnering Up Claudin 18.2 Agents（邦題意訳：中国バイオテック企業が急成長　CLDN18.2抗体で協業続々）」

https://scrip.pharmaintelligence.informa.com/SC147989/Chinese-Biotechs-Ascend-DealMaking-By-Partnering-Up-Claudin-182-Agents

世界の製薬業界ニュース Scrip（スクリップ）とは？

https://www.citeline.com/ja-jp/products-services/commercialization/scrip

In this special extra episode of Medtech Insight's podcast series on cardiovascular technology, editor Reed Miller talked to Vish Charan, the divisional vice president of product development in Abbott's cardiac rhythm management division.

[C#4052:Abbott] aspires to be a leader in development of "future-ready" cardiac rhythm management (CRM) devices that do not need to be frequently replaced or explanted.

Late last year, Medtech Insight talked to Leonard Ganz, Abbott’s CRM business as its divisional vice president of medical affairs and chief medical officer, to talk about the company's development of leadless CRM devices, including Aveir VR, the only leadless pacemaker with unique mapping capabilities that can be easily retrieved as the patient's need for new therapies change. ([A#MT145700])

To get the engineer's perspective on how Abbott is trying to keep up with [C#72:Boston Scientific] and [C#252:Medtronic] in this space, editor Reed Miller recently talked to Vish Charan, the vice president of product development in Abbott's CRM division.

Charan is all too familiar with the challenges of managing traditional cardiac leads, since he started his career as an engineer working on cardiac leads at [C#1191:St. Jude Medical]; he joined Abbott as an operations leader when Abbott acquired St. Jude about six years ago.

He also talked about his role with the company, the future of transvenous devices, and the potential to reach more patients earlier in the progression of arrhythmia to save lives and costs.

Use the player below to hear the whole interview.

Further Reading

For more information on leadless CRM technology discussed in this interview, check out these articles from Medtech Insight.

Minute Insight: Abbott Rolls Out Navitor Next-Gen TAVR System To Catch Up To Medtronic And Edwards

Medtronic’s Extravascular ICD Hits Targets In Trial; Will Soon Compete With Boston Scientific’s S-ICD

Exec Chat: Abbott Bets On Modular And Leadless Devices To Be The Future Of Cardiac Rhythm Management

Cardio Conversations: Abbott's Electrophysiology CMO Christopher Piorkowski On Cardiac Mapping, PFA, VT And More

Minute Insight: Abbott’s Aveir VR To Take On Medtronic’s Micra In US Leadless Pacemaker Market

Cardiovascular Catch-Up: Abbott Launches Trial Of Dual-Chamber Leadless Pacer; Cardialen Studies Low-Energy Arrhythmia Treatment; And More

Boston Scientific Advances First ‘Modular’ Cardiac Rhythm Management System

Further Listening

Our other podcasts are available on Apple Podcasts, Google Podcasts, SoundCloud and TuneIn - also now on Spotify Podcasts - and via smart speakers if one of these platforms has been set up as your default podcast provider.

국가신약개발사업단이 제약바이오업계를 지원하기 위해 어떻게 진화하고 있고 어떤 신규 프로젝트를 진행하고 있는 지에 대해 이야기한 묵현상 단장 인터뷰 기사를 요약한 내용입니다.

https://scrip.pharmaintelligence.informa.com/SC147745/The-Hunt-For-Big-Fish-How-KDDF-Is-Helping-Create-Korean-Deals

Gain valuable insight on the key strategies required to boost patient recruitment and retention rates, and improve diversity, in clinical trials.

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights how Alife Health is using its AI-based platform for IVF to increase chances for successful pregnancies while Barnaby Pickering discusses how AI Medical Technology is using AI to detect melanoma. Reed Miller talks about weight-loss device maker Allurion Technologies’ signed SPAC deal.

Medtech Insight articles addressing topics discussed in this episode:

Omar Ishrak’s SPAC Buys Allurion To Support Weight-Loss System

https://medtech.pharmaintelligence.informa.com/MT147624/Omar-Ishraks-SPAC-Buys-Allurion-To-Support-Weight-Loss-System

Alife Health Leverages AI Tools For IVF To Increase Access, Improve Chances For Successful Pregnancies

https://medtech.pharmaintelligence.informa.com/MT147660/Alife-Health-Leverages-AI-Tools-For-IVF-To-Increase-Access-Improve-Chances-For-Successful-Pregnancies

AI Medical Technology Doubles Down On Melanoma With Trials And Financing

https://medtech.pharmaintelligence.informa.com/MT147611/AI-Medical-Technology-Doubles-Down-On-Melanoma-With-Trials-And-Financing

GE HealthCare To Buy AI Imaging Firm Caption Health To Bolster Ultrasound Business

https://medtech.pharmaintelligence.informa.com/MT147626/GE-HealthCare-To-Buy-AI-Imaging-Firm-Caption-Health-To-Bolster-Ultrasound-Business

Minute Insight: MeThinks Secures CE Mark For AI-based Stroke Detection Product

https://medtech.pharmaintelligence.informa.com/MT147656/Minute-Insight-MeThinks-Secures-CE-Mark-For-AIbased-Stroke-Detection-Product

In this episode of Medtech Connect, Medtech Insight regulatory reporter Hannah Daniel interviews Scott Trevino, senior vice president of cybersecurity at TRIMEDX about the new cybersecurity oversight given to the FDA as a part of the 2023 Omnibus Appropriations bill passed in December.